Josh Lichtman

Josh Lichtman serves as the Chief Scientific Officer and Co-Founder at TCG Labs-Soleil since June 2023, contributing to large molecule compound and target discovery in the realm of metabolic disease treatment. Prior to this role, Lichtman held various positions at NGM Biopharmaceuticals from March 2015 to May 2023, including Vice President of Research, Associate Director of Bioinformatics, and Senior Scientist in Bioinformatics. Additional experience includes an internship focused on gut microbiota discovery, as well as research roles at Stanford University, Synthetic Genomics, and Hanson Technologies. Academic credentials include a Ph.D. in Chemical and Systems Biology from Stanford University, complemented by a certificate in Innovation and Entrepreneurship from Stanford's Graduate School of Business and a B.S. in Biochemistry and Molecular Biology from Dickinson College.